Annual Current Ratio
14.25
-3.02-17.49%
31 December 2023
Summary:
Keros Therapeutics annual current ratio is currently 14.25, with the most recent change of -3.02 (-17.49%) on 31 December 2023. During the last 3 years, it has fallen by -23.02 (-61.77%). KROS annual current ratio is now -61.77% below its all-time high of 37.27, reached on 31 December 2020.KROS Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
19.03
-1.34-6.58%
30 September 2024
Summary:
Keros Therapeutics quarterly current ratio is currently 19.03, with the most recent change of -1.34 (-6.58%) on 30 September 2024. Over the past year, it has increased by +0.80 (+4.39%). KROS quarterly current ratio is now -48.94% below its all-time high of 37.27, reached on 31 December 2020.KROS Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.5% | +4.4% |
| 3 y3 years | -61.8% | -7.3% |
| 5 y5 years | +539.0% | - |
KROS Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.8% | at low | -23.1% | +33.5% |
| 5 y | 5 years | -61.8% | +616.1% | -48.9% | +856.3% |
| alltime | all time | -61.8% | +616.1% | -48.9% | +856.3% |
Keros Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 19.03(-6.6%) |
| June 2024 | - | 20.37(-17.7%) |
| Mar 2024 | - | 24.74(+73.6%) |
| Dec 2023 | 14.25(-17.5%) | 14.25(-21.8%) |
| Sept 2023 | - | 18.23(-12.2%) |
| June 2023 | - | 20.77(-11.4%) |
| Mar 2023 | - | 23.43(+35.7%) |
| Dec 2022 | 17.27 | 17.27(-19.0%) |
| Sept 2022 | - | 21.33(+48.2%) |
| June 2022 | - | 14.39(-27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 19.85(-6.5%) |
| Dec 2021 | 21.23(-43.0%) | 21.23(+3.5%) |
| Sept 2021 | - | 20.52(-36.0%) |
| June 2021 | - | 32.06(+12.1%) |
| Mar 2021 | - | 28.60(-23.3%) |
| Dec 2020 | 37.27(+1772.9%) | 37.27(+86.4%) |
| Sept 2020 | - | 19.99(+11.6%) |
| June 2020 | - | 17.91(+170.1%) |
| Mar 2020 | - | 6.63(+233.2%) |
| Dec 2019 | 1.99(-10.8%) | 1.99 |
| Dec 2018 | 2.23 | - |
FAQ
- What is Keros Therapeutics annual current ratio?
- What is the all time high annual current ratio for Keros Therapeutics?
- What is Keros Therapeutics annual current ratio year-on-year change?
- What is Keros Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Keros Therapeutics?
- What is Keros Therapeutics quarterly current ratio year-on-year change?
What is Keros Therapeutics annual current ratio?
The current annual current ratio of KROS is 14.25
What is the all time high annual current ratio for Keros Therapeutics?
Keros Therapeutics all-time high annual current ratio is 37.27
What is Keros Therapeutics annual current ratio year-on-year change?
Over the past year, KROS annual current ratio has changed by -3.02 (-17.49%)
What is Keros Therapeutics quarterly current ratio?
The current quarterly current ratio of KROS is 19.03
What is the all time high quarterly current ratio for Keros Therapeutics?
Keros Therapeutics all-time high quarterly current ratio is 37.27
What is Keros Therapeutics quarterly current ratio year-on-year change?
Over the past year, KROS quarterly current ratio has changed by +0.80 (+4.39%)